Combination bronchodilator therapy in the management of chronic obstructive pulmonary disease

Chronic obstructive pulmonary disease (COPD) represents a significant cause of global morbidity and mortality, with a substantial economic impact. Recent changes in the Global initiative for chronic Obstructive Lung Disease (GOLD) guidance refined the classification of patients for treatment using a...

Descripción completa

Detalles Bibliográficos
Autores principales: Tashkin, Donald P, Ferguson, Gary T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3651866/
https://www.ncbi.nlm.nih.gov/pubmed/23651244
http://dx.doi.org/10.1186/1465-9921-14-49

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3651866/
https://www.ncbi.nlm.nih.gov/pubmed/23651244
http://dx.doi.org/10.1186/1465-9921-14-49

Ejemplares similares